Final results of a phase I trial of fasting prior to platinum-based chemotherapy.

被引：0
|
作者：
Quinn, David I.
Groshen, Susan G.
Shah, Manali
Tsao-Wei, Denice D.
Garcia, Agustin A.
Huyen Pham
Lin, Yvonne Gail
Ketchens, Charlean
Massopust, Kristy
Wei, Min
Longo, Valter
Dorff, Tanya B.
机构：
[1] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[2] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
[3] Univ So Calif, Los Angeles, CA USA
[4] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
[5] USC Davis Sch Gerontol, Los Angeles, CA USA
[6] Univ So Calif, Sch Gerontol, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9632
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Rationale for the combination of veliparib with platinum-based chemotherapy.
    Maag, David
    Solomon, Larry
    Hopkins, Todd
    Bukhofzer, Gail
    Shi, Yan
    Donawho, Cherrie
    Zhu, Gui-Dong
    Rodriguez, Luis E.
    Penning, Thomas
    DiGiammarino, Enrico
    Panchal, Sanjay C.
    Johnson, Eric Feral
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Safety and feasibility of fasting in combination with platinum-based chemotherapy
    Dorff, Tanya B.
    Groshen, Susan
    Garcia, Agustin
    Shah, Manali
    Tsao-Wei, Denice
    Huyen Pham
    Cheng, Chia-Wei
    Brandhorst, Sebastian
    Cohen, Pinchas
    Wei, Min
    Longo, Valter
    Quinn, David I.
    BMC CANCER, 2016, 16
  • [3] Safety and feasibility of fasting in combination with platinum-based chemotherapy
    Tanya B. Dorff
    Susan Groshen
    Agustin Garcia
    Manali Shah
    Denice Tsao-Wei
    Huyen Pham
    Chia-Wei Cheng
    Sebastian Brandhorst
    Pinchas Cohen
    Min Wei
    Valter Longo
    David I. Quinn
    BMC Cancer, 16
  • [4] A phase II trial with copanlisib plus avelumab as maintenance therapy for metastatic bladder cancer after platinum-based chemotherapy.
    Farrukh, Hizra
    Zhu, Zheng
    Zhu, Shaoming
    Montgomery, Robert Bruce
    Meeks, Joshua J.
    VanderWeele, David James
    Wong, Yu-Ning
    Lew, Robert A.
    Pan, Chong-xian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Phase I trial of ribociclib (LEE-011) with platinum-based chemotherapy in recurrent platinum sensitive ovarian cancer
    Coffman, Lan
    Orellana, Taylor
    Normolle, Daniel
    Courtney-Brooks, Madeleine
    Boisen, Michelle
    Olawaiye, Alexander
    Berger, Jessica
    Lesnock, Jamie
    Sukumvanich, Paniti
    Taylor, Sarah
    McLean, Karen
    Uppal, Shitanshu
    Buckanovich, Ronald
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S69 - S69
  • [6] Final results of a phase II trial of prolgolimab with platinum-based therapy and bevacizumab in patients with advanced cervical cancer
    Fogt, Sergey
    Andabekov, Timur
    Shamsutdinova, Yana
    Dvorkin, Mikhail
    Artamonova, Elena
    Chistyakov, Valerii
    Zukov, Ruslan
    Moiseenko, Vladimir
    Nechaeva, Marina
    Odintsova, Svetlana
    Fadeeva, Natalia
    Kislov, Nikolai
    Tantsyrev, Denis
    Tjulandin, Sergei
    Fomin, Eugeniy
    Linkova, Iuliia
    Zinkina-Orikhan, Arina
    Shustova, Mariia
    Zhukova, Lyudmila
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Early intervention with epoetin-alfa during platinum-based chemotherapy.
    Savonije, J
    Van Groeningen, C
    Van Bochove, A
    Pinedo, H
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 756S - 756S
  • [8] A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy
    Wenham, R.
    LaPolla, J.
    Lin, H.
    Apte, S.
    Roberts, W.
    Lancaster, J.
    Theodore, S.
    Fabri, D.
    Havrilesky, L.
    Alvarez-Secord, A.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S61 - S62
  • [9] Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy
    Wenham, R.
    LaPolla, J.
    Hui-Yi, L.
    Apte, S.
    Roberts, W.
    Lancaster, J.
    Bosquet, J. Gonzalez
    Theodore, S.
    Havrilesky, L.
    Alvarez-Secord, A.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S83 - S84
  • [10] A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy
    Wenham, Robert M.
    Lapolla, James
    Lin, Hui-Yi
    Apte, Sachin M.
    Lancaster, Johnathan M.
    Judson, Patricia L.
    Gonzalez-Bosquet, Jesus
    Herschberger, Amber
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2013, 130 (01) : 19 - 24
12345